{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T06:13:38Z","timestamp":1778912018448,"version":"3.51.4"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003970","name":"Isfahan University of Medical Sciences","doi-asserted-by":"publisher","award":["2404171"],"award-info":[{"award-number":["2404171"]}],"id":[{"id":"10.13039\/501100003970","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003970","name":"Isfahan University of Medical Sciences","doi-asserted-by":"publisher","award":["3402112"],"award-info":[{"award-number":["3402112"]}],"id":[{"id":"10.13039\/501100003970","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics: X"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijpx.2025.100457","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:35:54Z","timestamp":1764722154000},"page":"100457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The impact of the conjugation manner of targeting agent and tandem cell-penetrating peptide on the efficacy of mitomycin C liposomes in treating triple-negative breast tumors"],"prefix":"10.1016","volume":"10","author":[{"given":"Mehrnaz","family":"Salahi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaleh","family":"Varshosaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahboubeh","family":"Rostami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salar Nasr","family":"Esfahani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arsham","family":"Hekmat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Jahanian-Najafaabadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Minayian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpx.2025.100457_bb0005","first-page":"2899","article-title":"Damage-associated molecular patterns in cancer progression and therapy","volume":"24","author":"Aaes","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpx.2025.100457_bb0010","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1038\/s41598-018-22915-4","article-title":"Evaluation of the selective toxic effect of the charge switchable diethyldithiocarbamate-loaded nanoparticles between hepatic normal and cancerous cells","volume":"8","author":"Abu-Serie","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpx.2025.100457_bb0015","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2174\/1574892812666170424144925","article-title":"In vitro collapsing colon cancer cells by selectivity of disulfiram-loaded charge switchable nanoparticles against cancer stem cells","volume":"12","author":"Abu-Serie","year":"2017","journal-title":"Recent Pat. Anticancer Drug Discov."},{"key":"10.1016\/j.ijpx.2025.100457_bb0020","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1742-4658.2012.08529.x","article-title":"Glycosaminoglycans: key players in cancer cell biology and treatment","volume":"279","author":"Afratis","year":"2012","journal-title":"FEBS J."},{"key":"10.1016\/j.ijpx.2025.100457_bb0025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10637-023-01409-9","article-title":"Targeted delivery of liposomal Ribociclib to SLC7A5 transporters in breast cancer cells","volume":"42","author":"Afsharzadeh","year":"2024","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.ijpx.2025.100457_bb0040","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1021\/acs.bioconjchem.8b00429","article-title":"Selective uptake into drug resistant mammalian cancer by cell penetrating peptide-mediated delivery","volume":"29","author":"Carnevale","year":"2018","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ijpx.2025.100457_bb0045","first-page":"5123","article-title":"Hyaluronic acid-modified liposomes for targeted delivery of mitomycin C to triple-negative breast cancer","volume":"16","author":"Chen","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijpx.2025.100457_bb0050","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.3390\/ijms251910560","article-title":"Novel CD44-targeted albumin nanoparticles: an innovative approach to improve breast cancer treatment","volume":"25","author":"Cirillo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpx.2025.100457_bb0055","doi-asserted-by":"crossref","first-page":"1520078","DOI":"10.3389\/fcell.2024.1520078","article-title":"Nanoparticle accumulation and penetration in 3D tumor models: the effect of size, shape, and surface charge","volume":"12","author":"Cybulski","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ijpx.2025.100457_bb0060","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1039\/C6CS00592F","article-title":"Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment","volume":"46","author":"Dai","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ijpx.2025.100457_bb0065","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.2147\/IJN.S215941","article-title":"Development and screening of brain-targeted lipid-based nanoparticles with enhanced cell penetration and gene delivery properties","volume":"14","author":"Dos Santos Rodrigues","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijpx.2025.100457_bb0070","doi-asserted-by":"crossref","first-page":"1540192","DOI":"10.3389\/fimmu.2025.1540192","article-title":"Applications of cell penetrating peptide-based drug delivery in immunotherapy","volume":"16","author":"Du","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijpx.2025.100457_bb0075","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ijpx.2025.100457_bb0080","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/08982104.2018.1468774","article-title":"Physicochemical study of the protein-liposome interactions: influence of liposome composition and concentration on protein binding","volume":"29","author":"Foteini","year":"2019","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.ijpx.2025.100457_bb0085","doi-asserted-by":"crossref","first-page":"11282","DOI":"10.1038\/s41598-019-47568-9","article-title":"In silico design and optimization of selective membranolytic anticancer peptides","volume":"9","author":"Gabernet","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpx.2025.100457_bb0090","first-page":"343","article-title":"Promitil\u00ae (pegylated liposomal mitomycin-C lipid prodrug): phase I clinical trial results","volume":"38","author":"Gabizon","year":"2020","journal-title":"Investig. New Drugs"},{"issue":"7","key":"10.1016\/j.ijpx.2025.100457_bb0100","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.3390\/ijms21072536","article-title":"Nanoparticles modified with cell-penetrating peptides: conjugation mechanisms, physicochemical properties, and application in cancer diagnosis and therapy","volume":"21","author":"Gessner","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpx.2025.100457_bb0105","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2174\/156720107779314749","article-title":"Effects of lipid composition and preparation conditions on physical-chemical properties, technological parameters and in vitro biological activity of gemcitabine-loaded liposomes","volume":"4","author":"Grazia Calvagno","year":"2007","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ijpx.2025.100457_bb0115","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0927-7765(02)00048-6","article-title":"Preparation and physicochemical properties of various soybean lecithin liposomes using supercritical reverse phase evaporation method","volume":"27","author":"Imura","year":"2003","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijpx.2025.100457_bb0120","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1016\/j.ejca.2008.09.034","article-title":"What is triple-negative breast cancer?","volume":"44","author":"Irvin","year":"2008","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ijpx.2025.100457_bb0125","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.2147\/IJN.S488961","article-title":"Advancements in liposomal nanomedicines: innovative formulations","volume":"20","author":"Izadiyan","year":"2025","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijpx.2025.100457_bb0130","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jconrel.2015.12.009","article-title":"Reactive oxygen species responsive drug releasing nanoparticle based on chondroitin sulfate-anthocyanin nanocomplex for efficient tumor therapy","volume":"222","author":"Jeong","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2025.100457_bb0135","doi-asserted-by":"crossref","first-page":"11413","DOI":"10.1021\/am501932s","article-title":"Development of both methotrexate and mitomycin C loaded PEGylated chitosan nanoparticles for targeted drug codelivery and synergistic anticancer effect","volume":"6","author":"Jia","year":"2014","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"11","key":"10.1016\/j.ijpx.2025.100457_bb0140","first-page":"2171","article-title":"Cancer targeting peptides","volume":"76","author":"Kalmouni","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ijpx.2025.100457_bb0145","first-page":"4757","article-title":"Stimuli-responsive CS-based nanoplatforms in cancer therapy","volume":"17","author":"Khan","year":"2022","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijpx.2025.100457_bb0150","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Classification of cell death: Recommendations of the nomenclature committee on cell death 2018","volume":"25","author":"Kroemer","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ijpx.2025.100457_bb0160","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1021\/acssuschemeng.9b06220","article-title":"Poly-L-arginine as a high-performance and biodegradable shale inhibitor in water-based drilling fluids for stabilizing wellbore","volume":"8","author":"Li","year":"2020","journal-title":"ACS Sustain. Chem. Eng."},{"key":"10.1016\/j.ijpx.2025.100457_bb0165","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.canlet.2016.04.002","article-title":"The autophagy inhibitor chloroquine targets cancer stem cells in triple negative breast cancer by inducing mitochondrial damage and impairing DNA break repair","volume":"376","author":"Liang","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ijpx.2025.100457_bb0170","first-page":"323","article-title":"LyP-1\/chondroitin sulfate dual-targeted liposomes enhance chemo-immunotherapy in TNBC","volume":"358","author":"Luo","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2025.100457_bb0175","doi-asserted-by":"crossref","DOI":"10.1177\/10732748211066311","article-title":"From apoptosis to necroptosis: the death wishes to cancer","volume":"28","author":"Meng","year":"2021","journal-title":"Cancer Control"},{"key":"10.1016\/j.ijpx.2025.100457_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.133625","article-title":"Chondroitin sulfate\u2013tocopherol succinate modified exosomes for targeted drug delivery to CD44-positive cancer cells","volume":"275","author":"Mohammadi","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijpx.2025.100457_bb0185","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/ijc.22424","article-title":"Chondroitin sulfate glycosaminoglycans as major P-selectin ligands on metastatic breast cancer cell lines","volume":"120","author":"Monzavi-Karbassi","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ijpx.2025.100457_bb0190","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1080\/21691401.2016.1200059","article-title":"Enhancing antitumor activity of silver nanoparticles by modification with cell-penetrating peptides","volume":"45","author":"Mussa Farkhani","year":"2017","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.ijpx.2025.100457_bb0195","first-page":"539","article-title":"Apoptosis, necroptosis, and pyroptosis: an intricate game of cell death","volume":"171","author":"Najafov","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ijpx.2025.100457_bb0200","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.lfs.2015.02.025","article-title":"P-selectin enhances growth and metastasis of mouse mammary tumors by promoting regulatory T cell infiltration into the tumors","volume":"131","author":"Nasti","year":"2015","journal-title":"Life Sci."},{"key":"10.1016\/j.ijpx.2025.100457_bb0205","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/cancers9090116","article-title":"Exploring the role of RGD-recognizing integrins in cancer","volume":"9","author":"Nieberler","year":"2017","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijpx.2025.100457_bb0210","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.ejca.2010.02.024","article-title":"CD44, a therapeutic target for metastasising tumours","volume":"46","author":"Orian-Rousseau","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ijpx.2025.100457_bb0215","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1039\/D4BM00478G","article-title":"Improved anti-breast cancer activity by doxorubicin-loaded super stealth liposomes","volume":"12","author":"Paolino","year":"2024","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ijpx.2025.100457_bb0220","first-page":"361","article-title":"Advances in chondroitin sulfate-based nanoplatforms for biomedical applications","volume":"19","author":"Peng","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ijpx.2025.100457_bb0225","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41392-022-01110-y","article-title":"Regulated cell death (RCD) in cancer: key pathways and targeted therapies","volume":"7","author":"Peng","year":"2022","journal-title":"Sig. Transduc. Target. Ther."},{"key":"10.1016\/j.ijpx.2025.100457_bb0230","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/sj.cdd.4401062","article-title":"Mitomycin C induces apoptosis and caspase-8 and -9 processing through a caspase-3 and Fas-independent pathway","volume":"9","author":"Pirnia","year":"2002","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ijpx.2025.100457_bb0235","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18477","article-title":"Liposome conjugation of cell penetrating peptides enhances cellular delivery of a tau aggregation inhibitor","volume":"28","author":"Reich","year":"2024","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ijpx.2025.100457_bb0240","doi-asserted-by":"crossref","first-page":"399","DOI":"10.5650\/jos.ess15229","article-title":"Influence of lipid composition, pH, and temperature on physicochemical properties of liposomes with curcumin as model drug","volume":"65","author":"Roy","year":"2016","journal-title":"J. Oleo Sci."},{"key":"10.1016\/j.ijpx.2025.100457_bb0245","first-page":"397","article-title":"Peptide ligand-modified nanoparticles for deep tumor penetration and efficient in vivo targeting therapy","volume":"30","author":"Song","year":"2016","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijpx.2025.100457_bb0250","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41392-023-01642-x","article-title":"Smart nanoparticles for cancer therapy","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijpx.2025.100457_bb0255","first-page":"1245","article-title":"Regulated cell death in cancer: from molecular mechanisms to therapeutic opportunities","volume":"15","author":"Trindade","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"20","key":"10.1016\/j.ijpx.2025.100457_bb0260","first-page":"12345","article-title":"Polymeric micelle delivery of mitomycin C for enhanced tumor penetration and antitumor activity in breast cancer","volume":"12","author":"Wang","year":"2022","journal-title":"RSC Adv."},{"issue":"15","key":"10.1016\/j.ijpx.2025.100457_bb0265","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.3390\/cancers13153697","article-title":"Triple negative breast cancer: a mountain yet to be scaled despite the triumphs","volume":"13","author":"Wu","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ijpx.2025.100457_bb0270","first-page":"1604","article-title":"Dual-ligand liposomes for tumor-targeted drug delivery: pharmacokinetics and biodistribution","volume":"14","author":"Xu","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2025.100457_bb0275","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.3390\/life13112158","article-title":"Preparing size-controlled liposomes modified with polysaccharide derivatives for pH-responsive drug delivery applications","volume":"13","author":"Yanagihara","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.ijpx.2025.100457_bb0280","first-page":"108","article-title":"Hyaluronic acid\u2013coated albumin nanoparticles for targeted delivery to CD44-overexpressing melanoma cells","volume":"16","author":"Yang","year":"2018","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ijpx.2025.100457_bb0285","first-page":"1912","article-title":"Enhanced immunocompatibility of ligand-targeted liposomes by attenuating natural IgM absorption","volume":"9","author":"Zhang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpx.2025.100457_bb0290","first-page":"4757","article-title":"Stimuli-responsive nanoplatforms for controlled drug release","volume":"17","author":"Zhang","year":"2022","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijpx.2025.100457_bb0295","first-page":"1743","article-title":"Chondroitin sulfate-modified liposomes for targeted co-delivery of doxorubicin and retinoic acid to suppress breast cancer lung metastasis","volume":"16","author":"Zhou","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijpx.2025.100457_bb0300","first-page":"243","article-title":"Charge-reversal nanomedicines as a smart bullet for deep tumor penetration","volume":"3","author":"Zimu","year":"2022","journal-title":"Smart Mater. Med."},{"key":"10.1016\/j.ijpx.2025.100457_bb0305","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nrc3023","article-title":"CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?","volume":"11","author":"Zoller","year":"2011","journal-title":"Nat. Rev. Cancer"}],"container-title":["International Journal of Pharmaceutics: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156725001422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156725001422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T06:05:07Z","timestamp":1778911507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590156725001422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":56,"alternative-id":["S2590156725001422"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpx.2025.100457","relation":{},"ISSN":["2590-1567"],"issn-type":[{"value":"2590-1567","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of the conjugation manner of targeting agent and tandem cell-penetrating peptide on the efficacy of mitomycin C liposomes in treating triple-negative breast tumors","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpx.2025.100457","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100457"}}